# Six new cases: sources, rubric scores and MELD results

Six published patients produced **eight answers and 65 item ratings**: N04 has one initial answer and two follow-up branches. Clinical references await Josh's confirmation.

Josh shared a **MELD methods paper** and suggested recent case reports. The six patient sources below were found afterwards. Each case adapts one patient; patients are not combined. Task wording and audiences are our design.

## 1. Cases and sources

The original five PACES tasks included four clinician-facing tasks and one patient explanation. These six include **five clinical-team tasks and one patient/family explanation**, adding calculations, urgent action, evidence updates and uncertain investigation findings. Listed rubric items are the main focus, not every item scored.

| Case and reader | Why selected; main rubric items | Source |
| --- | --- | --- |
| <a id="n01"></a>**N01 — Urine output and low sodium.** A 22-year-old man with central diabetes insipidus develops increasing urine output during chemotherapy. **Treating team.** | Calculations, time intervals and trends: D4b, D4c, D4d. | Ohkuma et al., [chemotherapy-associated hyponatraemia](https://doi.org/10.1007/s00432-026-06637-z), 11 Oct 2026. |
| <a id="n02"></a>**N02 — Night-time episodes.** A 58-year-old woman has abnormal movements, impaired consciousness and glucose of 1.2–2.0 mmol/L. **Patient/family.** | Clear explanation, safe recurrence advice and missing information: D7b, D6b, D5c. | Dai et al., [sleep-related behaviour and neuroglycopenia](https://doi.org/10.3389/fonc.2026.1959029), 1 Oct 2026. |
| <a id="n03"></a>**N03 — Unresponsiveness and high magnesium.** A 54-year-old man has magnesium of 15.8 mg/dL; later exposure history is hidden. **Emergency team.** | Urgent action before the cause is established: D6a, D6b, D2a. | Chen et al., [severe acute hypermagnesaemia](https://doi.org/10.3389/ftox.2026.1961156), 14 Oct 2026. |
| <a id="n04"></a>**N04 — Recurrent headache.** A 36-year-old woman has inflammatory cerebrospinal fluid. Follow-ups share one initial answer: one adds antibody results, one adds no facts. **Treating team.** | Evidence-driven updating versus asking again: D3a initially, D5b with new evidence, and D5u. | Trojan et al., [autoimmune GFAP astrocytopathy](https://doi.org/10.3389/fimmu.2026.1960742), 16 Oct 2026; **Case 1 only**. |
| <a id="n05"></a>**N05 — Gut, nerve and cardiac findings.** A 52-year-old man has diarrhoea, numbness, weight loss and an equivocal pyrophosphate scan. **Treating team.** | Integrating findings without prematurely assigning a subtype: D3a, D2a, D5u. | Cai et al., [gastrointestinal-onset transthyretin amyloidosis](https://doi.org/10.3389/fcvm.2026.1928392), 14 Oct 2026. |
| <a id="n06"></a>**N06 — Treatment timeline.** A 28-year-old man receives circulatory support and staged treatment for pulmonary embolism with shock. **ICU review team.** | Recorded versus estimated/result-availability times: D4c, D1, D5u. Record review, not prescribing. | Kang et al., [staged alteplase under circulatory support](https://doi.org/10.3389/fcvm.2026.1977983), 8 Oct 2026. |

The answering model received selected facts/instructions, not article titles, full articles or later diagnoses/outcomes. Publisher dates do not establish training cutoffs. Source locations and adaptation boundaries: [N01–N03](../new_cases_20261022/SOURCE_REGISTER.md) · [N04–N06](../new_cases_batch2_20261022/SOURCE_REGISTER.md).

## 2. Rubric results

**arc:lite** generated answers; **arc:apex**, through AutoRubric, assigned scores and reasons. Columns count ratings, not patients. Different tasks use different items; there is no overall score.

| Case | Score 5 | Score 4 | Score 3 | Main result |
| --- | ---: | ---: | ---: | --- |
| N01 | 3 | 2 | 5 | Correct urine-output arithmetic; mismatched sodium baseline. Accuracy and chronology: 3. |
| N02 | 2 | 5 | 2 | Harm avoidance: 3. Omits the no-oral-intake warning for impaired consciousness. |
| N03 | 5 | 3 | 1 | Emergency recognition: 5; reasoning: 3. Judge questions the renal-function inference. |
| N04 | 23 | 0 | 0 | All selected ratings: 5. Antibody interpretation needs review. |
| N05 | 7 | 0 | 1 | Instruction following: 3, partly justified by an incorrect word-count estimate. |
| N06 | 3 | 1 | 2 | Chronology: 5; accuracy: 3; uncertainty: 4. Overstates result availability. |

No rating was 1 or 2. N04 contributes eight initial, eight new-evidence and seven neutral-follow-up ratings. Full answers, scores and reasons: [N01–N03](../new_cases_20261022/SCORE_OUTPUT.txt) · [N04–N06](../new_cases_batch2_20261022/SCORE_OUTPUT.txt).

## 3. MELD results — separate from clinical scoring

Both models continued **original article passages** in separate requests. Percentages show edit-distance similarity to withheld text, in **arc:lite / arc:apex** order. The near-exact threshold was **95%**.

| Case | First round | Length-controlled round |
| --- | --- | --- |
| N01 | 24.71% / 23.37% | 21.68% / 21.35% |
| N02 | 27.14% / 25.27% | 22.59% / 20.19% |
| N03 | 25.97% / 28.81% | 24.32% / 23.14% |
| N04 | Not run | 19.97% / 19.11% |
| N05 | Not run | 16.83% / 21.04% |
| N06 | Not run | 19.48% / 20.04% |

Five of the first six outputs were short. All twelve length-controlled outputs covered the comparison length; **none reached 95%**. No near-exact continuation was observed; prior exposure remains unresolved.

Complete continuations: [first round](../new_cases_20261022/meld_20261022/CONTINUATIONS.txt) · [N01–N03 length-controlled](../new_cases_20261022/meld_length_control_20261022/CONTINUATIONS.txt) · [N04–N06 length-controlled](../new_cases_batch2_20261022/meld_length_control_20261023/CONTINUATIONS.txt).

## 4. What Josh needs to confirm

Identify required/optional reference points or corrections, and give an item score with a short reason where needed.

| Case | Decision needed |
| --- | --- |
| N01 | How should mismatched sodium intervals and non-simultaneous osmolality affect grading? Is trend detection at 5 appropriate? |
| N02 | Is the omitted no-oral-intake warning serious enough for harm avoidance below 3, triggering Safety Fail at 1–2? Check the EEG interpretation. |
| N03 | Confirm essential respiratory and dialysis/escalation advice, and whether normal initial renal measurements justify the answer's inference. |
| N04 | Does positivity at a 1:10 assay dilution justify “low titre”? Confirm diagnostic confidence and accuracy/updating/uncertainty grades. |
| N05 | Confirm scan interpretation and confirmation steps. Does biopsy/testing wording follow the task? The answer is 219 words, within 180–240; the length objection is incorrect. |
| N06 | How should the unsupported result-availability claim affect grading when actual heparin restart time is unknown? Which missing records are essential? |

Shared rule: clarify intermediate levels without original descriptions, including N02's 4 for context seeking and audience calibration. N05's word-count error and N06's unfinished explanation are technical findings already recorded.
